Entacapone
Entacapone is a premium-grade, yellow crystalline powder catechol-O-methyltransferase (COMT) inhibitor compound carrying CAS number 130929-57-6. Refined under strict pharmaceutical quality compliance, this high-purity substance exhibits exceptional selective enzymatic inhibition performance in neurological applications. Therefore, it provides reliable therapeutic adjunct efficacy across diverse anti-Parkinsonian formulation systems. Consequently, it serves as an ideal core choice for manufacturing specialized pharmaceutical tablets, advanced neurological therapeutic medicines, and modern clinical supportive care lines globally.
Description
Zyntex supplies high-purity Entacapone (CAS 130929-57-6) tailored for global pharmaceutical manufacturing plants. It is ideal for neurological drug factories and specialized synthesis laboratories.
Functioning as a highly specific selective enzyme inhibitor, it disrupts localized catecholamine degradation paths rapidly. Furthermore, it delivers precise substance profiles that ensure uniform dry batch integration. Its strictly minimized impurity variations and optimized crystalline geometry make it an ideal selection. Consequently, it fits sensitive tablet compression profiles and continuous pharmaceutical solution blending perfectly. Accordingly, formulation engineers specify this active substance to stabilize modern neurological therapeutic carriers. This practice maintains exact therapeutic integrity across continuous processing cycles.
Enzymatic Inhibition Efficiency and Stability
Excellent crystalline solubility performance in organic solvents and outstanding selective affinity provide a distinct operational edge. This advantage is crucial when engineering modern fast-acting neurological formulations. This active pharmaceutical solid operates by facilitating the reversible inhibition of catechol-O-methyltransferase systematically. Thus, it successfully enhances the bioavailability profiling of targeted levodopa therapeutic matrices. It supplies the exact chemical mechanisms required to induce rapid clinical response effects. As a consequence, it does this without altering raw batch density uniformity.
It assists processing engineers in maintaining strict active concentration uniformity. This balance is critical across high-speed pharmaceutical synthesis operations and continuous crystallization lines. Hence, it mitigates trace precipitation risks within automated volumetric feeding systems. For instance, specialized manufacturing facilities incorporate this refined pharmaceutical powder. It acts as a core active component in targeted Parkinson’s disease management and specialized neurological cycles. Consequently, it maximizes the technical throughput of automated formulation machinery. Consequently, Zyntex coordinates clean room synthesis paths to eliminate downstream moisture-induced alterations from your factory schedule.
Synthesis Reliability and Logistics
In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale manufacturing operations. This service supports advanced pharmaceutical synthesis centers globally. The compound maintains its refined crystalline geometry under strict storage parameters. Therefore, it prevents temperature-induced structural degradation or premature caking during automated mechanical blending steps. It advances contemporary pharmaceutical engineering by providing a thoroughly analyzed, highly predictable raw material. This product fully meets international therapeutic purity monographs.
Simultaneously, it remains a critical standard for routine high-performance liquid chromatography (HPLC) calibration assays. It also supports specialized neurological catalyst validation testing loops. In brief, our product functions as a dependable chemical foundation. It successfully supports both the performance of commercial therapeutic batches and the analytical rigor of specialized industrial laboratories.
Primary Industrial Sectors for Entacapone
This high-purity crystalline active pharmaceutical compound delivers crucial technical value within these four primary industrial sectors:
💊 Neurological Therapeutics
Primary therapeutic source used for adjunct therapy in Parkinsonian management. Hence, it directly supports optimal clinical dosage lines.
⚗️ Synthesis Intermediates
Utilized as a high-purity active base to compound professional neurological building blocks. Clearly, it is key for uniform metabolic performance.
🩺 Clinical Supportive Care
Acts as an essential active standard for manufacturing specialized chronic movement disorder medicines. Resultantly, it guarantees excellent matrix consistency.
🔬 Analytical Assays
Used as a professional high-purity reference material for validating advanced metabolic kinetics. Specifically, it confirms optimal therapeutic activity.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Entacapone |
| Assay / Purity | Min 98.0% – 101.0% (Pharma Grade) |
| Appearance | Yellow crystalline powder |
| Stability | Stable under normal conditions; protect from light |
| CAS Number | 130929-57-6 |
⚠️ WARNING / Safety & Handling: Entacapone is a stable therapeutic compound but may cause mild skin or eye irritation upon dust exposure. Avoid intense inhalation of powder. Store in sealed containers in a cool, dry area away from light. Use appropriate PPE (gloves, mask) during handling. Review the Safety Data Sheet (SDS) for detailed protocols.
